FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

455611000001103: Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16453901000001111 Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37775101000001118 Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Product containing precisely captopril 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Captopril false Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Capoten true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Captopril true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 56 tablet 4 x 14 tablets Is pack of False Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 84 tablet 6 x 14 tablets Is pack of False Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 56 tablet 4 x 14 tablets Has AMP True Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 84 tablet 6 x 14 tablets Has AMP True Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Capoten 25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start